I-Revues
ContactSearch
Showing 10 out of a total of 69 results for community: Atlas of Genetics and Cytogenetics in Oncology and Haematology - 2017. (0.005 seconds)
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Although T-cell/histiocyte rich large B-cell lymphoma (THRLBCL) is an aggressive diffuse large B-cell lymphoma (DLBCL), its morphology can resemble nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). These two entities are closely related: both diseases contain neoplastic cells with similar morphologic and immunophenotypic features but differ with respect to their architecture and the nature of the reactive background. Due to the overlapping features between THRLBCL and NLPHL, it is sometimes impossible to distinguish these two entities; thus, ""grey zone"" lymphoma is used to define some of those cases. Because of the morphologic and immunophenotypic similarities between THRLBCL and NLPHL, it is possible that these two entities may represent different stages of the same disease. A possible biological relation of THRLBCL with NLPHL has been suggested. Overlapping recurrent genetic abnormalities (gain of 4q and loss of 19p) might be the genetic link between THRLBCL and NLPHL....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Forty five cases carrying the t(2;11)(p21;q23) have been reported in the literature, mostly in myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Some of these cases involve rearrangements of the the MLL gene (also known as KMT2A), on 11q23, which confers a more aggressive behavior in myeloid neoplasms. Several individual case reports, as well as series such as 19 cases reported by Bousquet et al., 2008 and 7 cases by Dvorak et al., 2014, describe myeloid neoplasms carrying the t(2;11)(p21;q23) without an MLL gene rearrangement, with possible prognostic implications. The authors of this paper describe two additional cases from their institution....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(1;12)(p36;p13) translocations, with data on clinics, and the genes involved....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)This CARD addresses the following questions: 1) how should in situ follicular neoplasia be defined and diagnosed? and 2) how should people/patients with in situ follicular neoplasia be managed?...
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(1;7)(p36;p12) translocations, with data on clinics, and the genes involved....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(7;12)(q36;p13), with data on clinics, and the genes involved....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(1;3)(p36;q21) PSMD2/PRDM16 ???...
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(1;3)(p36;q21) translocations, with data on clinics, and the genes involved....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(1;17)(p36;q21) translocation, with data on clinics, and the genes involved....
-
(ARMGHM - Atlas Génétique des Cancers, 2017)Review on t(1;22)(p36;q11) IGL/PRDM16 translocations, with data on clinics, and the genes involved....
Author
Subject
Date Issued
